The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 2, 2007, Pages 273-277

  Williams, Adam N ^a   Simon, Ronald A ^a   Woessner, Katharine M ^a   Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Aspirin; aspirin challenge; aspirin desensitization; aspirin exacerbated respiratory disease; asthma; chronic rhinosinusitis; leukotriene modifier drugs; leukotrienes; nasal polyposis; nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DECONGESTIVE AGENT; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RANITIDINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CONTROLLED STUDY; DESENSITIZATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SENSITIZATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; OUTPATIENT; PRIORITY JOURNAL; PROVOCATION TEST; SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 34547116626     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.03.020     Document Type: Article

References (21)

1. Stevenson D.D., and Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118 (2006) 773-786
2. Sweet J.A., Stevenson D.D., Simon R.A., and Mathison D.A. Long-term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 86 (1990) 59-65
3. Stevenson D.D., Hankammer M.A., Mathison D.A., Christensen S.C., and Simon R.A. Long-term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 98 (1996) 751-758
4. Stevenson D.D., Simon R.A., and Zuraw B.L. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Adkinson N.F., Yuninger J.W., Busse W.W., Bochner B.S., Holgate S.T., and Simons F.E.R. (Eds). Middleton's allergy principles and practice. 6th ed. (2003), Mosby, Philadelphia 1695-1710
5. White A.A., Stevenson D.D., and Simon R.A. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 95 (2005) 330-335
6. Stevenson D.D., and Simon R.A. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 118 (2006) 801-804
7. Stevenson D.D. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 24 (2003) 159-167
8. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Clin Allergy Immunol 111 (2003) 180-186
9. Mascia K., Haselkorn T., Deniz Y.M., Miller D.P., Bleeecker E.R., and Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 116 (2005) 970-975
10. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 111 (2003) 913-921
11. 4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 104 (1999) 559-564
12. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143 (1991) 1025-1029
13. 4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 146 (1992) 96-103
14. Ferreri N.R., Howland W.C., Stevenson D.D., and Spiegelberg H.L. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 137 (1988) 847-854
15. Fischer A.R., Rosenberg M.A., Lilly C.M., Callery J.L., Rubin P., and Cohn P. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 94 (1994) 1046-1056
16. Kowalski M.L., Sliwinska-Kowalska M., Igarashi Y., White M.V., Wojciechowska B., Brayron P., et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 91 (1993) 580-598
17. Sladek K., Dworski R., Soja J., Sheller J.R., Nizankowska E., Oates J.A., et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 149 (1994) 940-946
18. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173 (2004) 1503-1510
19. Sousa A., Parikh A., Scadding G., Corrigan C.J., and Lee T.H. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 347 (2002) 1524-1526
20. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 32 (2002) 1491-1496
21. White A., Ludington E., Mehra P., Stevenson D.D., and Simon R.A. Effect of leukotriene modifier drugs on the safety of OACs. Ann Allergy Asthma Immunol 97 (2006) 688-693